Description
This chapter is dedicated to detailing new, evidence-based treatments for mold illness and explaining how to effectively diagnose and treat mold-related disease and chronic inflammatory response syndrome (CIRS).
The chapter will review the groundbreaking work and current standard of care, the Shoemaker protocol for CIRS (CSCSPC), and demonstrate how peptides can augment and replace many aspects of this protocol to achieve faster recovery and superior efficacy. This chapter will also cover the symptoms and consistent pathophysiology associated with mold illness, illustrating the multisystem pathophysiology seen with mold patients and emphasizing the diagnosis and treatment of immune dysfunction, a hallmark of CIRS. In addition, this section will review the literature on effective methods of mold remediation and explain the use of peptides to treat mold illness, as well as the correlation between the degree of immune dysfunction, specifically the severity of T cell exhaustion, immunosenescence, and the Th1/Treg to Th2/Th17 shift and the severity of this multisystem condition, CIRS.